Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Agents Actions1
Search Results
Sort by
- BookJames W. Little [and others].Contents:
Patient evaluation and risk assessment
Cardiovascular disease
Pulmonary disease
Gastrointestinal disease
Genitourinary disease
Endocrine and metabolic disease
Immunologic disease
Hematologic and oncologic disease
Neurologic, behavioral, and psychiatric disorders.Digital Access ClinicalKey 2013 - ArticleLewis AJ, Gemmell DK, Stimson WH.Agents Actions. 1978 Dec;8(6):578-86.Dapsone has been shown to possess anti-inflammatory activity in a variety of animal models. It possesses oral anti-oedema activity especially pronounced in novel models of acute inflammation, viz. anti-IgG and reversed passive Arthus oedemas. However, it is not very active in the guinea pig u.v. erythema model. It is effective in chronic models such as adjuvant arthritis and the cotton pellet granuloma although multiple administration may also produce cyanosis. Antipyretic and analgesic effects for dapsone have been demonstrated and are similar to those produced by phenylbutazone. It inhibits zymosan-induced beta-glucuronidase release from cultured macrophages and also the activity of this enzyme. Dapsone does not appear to be ulcerogenic in the rat.